Register Login
Register to leave comments
  • News bot May 4, 2026, 11:57 a.m.

    📋 TWIST BIOSCIENCE CORP (TWST) - Financial Results

    Filing Date: 2026-05-04

    Accepted: 2026-05-04 07:21:04

    Event Type: Financial Results

    Event Details:

    TWIST BIOSCIENCE CORP (TWST) Reports the reporting period Financial Results TWIST BIOSCIENCE CORP (TWST) announced its financial results for the period ending the reporting period. Key Financial Highlights:
    • Revenue: 15000
    • Net Income: Not disclosed
    • EPS: Not disclosed
    • Cash and equivalents: 122670
      • "We had a strong performance in the first half of fiscal 2026, ending the second quarter with our thirteenth consecutive quarter of growth. Revenue exceeded guidance, coming in at $
      • 7 million, growth of over 19% compared to the second quarter of 2025," said Emily M. Leproust, Ph.D., CEO and co
      • founder of Twist Bioscience. "As we look ahead, we remain focused on delivering consistent, measurable growth designed to scale over time. We expect to chart toward profitability while simultaneously building on the strong momentum we are seeing across the portfolio. We continue to anticipate achieving adjusted EBITDA breakeven in the fourth quarter of fiscal 2026 while holding gross margin above 52% for the fiscal year." See "Non

    📊 Key Financial Metrics (Year-over-Year Comparison):

    Metric 2026 2025 Change ($) Change (%)
    Revenue 92.79K 92.79K $0.00 +0.00%
    Costs And Expenses Loss From Operations -41.56K -41.56K $0.00 +0.00%
    Costs And Expenses Interest Income 2.80K 2.80K $0.00 +0.00%
    Costs And Expenses Total Other Income Expense 646.00 -487.00 $1.13K +232.65%
    Costs And Expenses Net Loss -39.33K -39.33K $0.00 +0.00%
    Costs And Expenses Net Loss Per Share -0.66 -0.66 $0.00 +0.00%
    Costs And Expenses Weighted Average Shares 61.39K 59.40K $1.98K +3.34%
    Current Assets Prepaid Expenses Other Current Assets 54.10K 15.20K $38.90K +255.83%
    Current Assets Property Equipment Net 111.23K 102.28K $8.94K +8.74%
    Current Assets Operating Lease Right Of Use Assets 70.66K 49.38K $21.28K +43.09%
    Current Assets Investment Equity Securities 68.09K 54.34K $13.75K +25.31%
    Current Liabilities Accounts Payable 14.68K 14.68K $0.00 +0.00%
    Add Deduct Adjustments Interest Income -2.80K -3.88K $1.08K +27.90%
    Add Deduct Adjustments Total Other Income Expense -646.00 487.00 $-1.13K -232.65%
    Revenue 92.79K 92.79K $0.00 +0.00%
    Selling, General & Administrative 145.83K 119.85K $25.98K +21.68%
    Loss from Operations -41.56K -41.56K $0.00 +0.00%
    Interest Income 2.80K 2.80K $0.00 +0.00%
    Net Loss -39.33K -39.33K $0.00 +0.00%
    Prepaid Expenses and Other Current Assets 15.20K 15.20K $0.00 +0.00%
    Property and Equipment, Net 102.28K 102.28K $0.00 +0.00%
    Investment in Equity Securities 54.34K 54.34K $0.00 +0.00%
    Accounts Payable 11.09K 11.09K $0.00 +0.00%

    💼 Business Developments:

    • Partnership
    • Acquisition: Not available
    • Licensing
    • Regulatory Approval: Not available
    • Executive Changes: Not available

    Structured Data:

    • Company Name: TWIST BIOSCIENCE CORP
    • Ticker Symbol: TWST

Search

News categories